Kevin Ryan’s AlleyCorp raises new $335 million fund, all in on early-stage bets

Kevin Ryan’s AlleyCorp has raised a $335 million second fund focused on early-stage investments in healthcare, deep tech, and general tech. The firm, previously a family office, now has eight unicorns in its portfolio and has backed psychedelic research initiatives and companies like Transcend Therapeutics, which was sold for $1.2 billion.